10 hours ago · The Food and Drug Administration says it will offer ultra-fast review to three psychedelic drugs being studied for hard-to-treat mental health conditions, including major depression.

Apr 18, 2026 · President Trump has signed an executive order to make certain psychedelic drugs more available to treat mental health conditions, such as depression and anxiety. He directed $50 million …

9 hours ago · The FDA fast‑tracked reviews of three psychedelic drugs after Trump's order speeding research on depression and PTSD treatments.

3 days ago · The list of products receiving FDA Commissioner priority review vouchers will grow this week to include three psychedelic drugs.

10 hours ago · WASHINGTON (AP) — The Food and Drug Administration said Friday it will offer ultra-fast review to three psychedelic drugs being developed to treat mental health conditions, including …

The FDA has announced an "ultra-fast" review of three psychedelic drugs aimed at treating mental health conditions including depression, signaling a significant commitment from the Trump ...

6 days ago · The Republican president said his directive will help "dramatically accelerate" access to research and treatments on psychedelic drugs.

5 days ago · President Donald Trump has ordered the FDA to perform priority reviews of psychedelic drugs as part of a push to clear barriers to access to treatments for serious mental illnesses.

6 days ago · President signed executive order directing FDA to expedite review of psychedelic drugs including ibogaine Donald Trump on Saturday announced reforms intended to speed up access to …

5 days ago · President Donald Trump has signed an executive order directing the US Food and Drug Administration (FDA) to expedite regulatory review of psychedelic drugs, including ibogaine …